Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Medicine|March 24, 2025
Sporadic pancreatic desmoid-type fibromatosis with curative resection: A case reportJiayao Zhang, Chenming Liu, Fangzheng Zhou, et al.
Frontiers in Oncology|July 3, 2026
Correction: Stereotactic radiotherapy for brain metastases: indications, dose fractionation, technological innovations, and evolving combination strategies - a comprehensive reviewHu Chen, Shuai Li, Qiuyu Yang, et al.
Scientific Reports|April 4, 2025
Evaluation of radiographic knee OA progression after arthroscopic meniscectomy compared with IACI for degenerative meniscus tearHairui Zhang, Zhiyao Zhao, Fangzheng Zhou, et al.
Frontiers in Oncology|May 11, 2026
Stereotactic radiotherapy for brain metastases: indications, dose fractionation, technological innovations, and evolving combination strategies - a comprehensive reviewHu Chen, Shuai Li, Qiuyu Yang, et al.
Orthopedics|February 26, 2026
Exceptional Massive Calcification of the Medial Collateral Ligament: A Case Linked to Underlying Lung NeoplasmHuaifeng Ta, Jingjing Yang, Xiaoning Liu, et al.
Orthopaedic Journal of Sports Medicine|April 29, 2026
Deep Learning-Based Automatic Glenohumeral Joint Segmentation for Determining Whether the Hill-Sachs Lesion Is On-Track or Off-TrackFangzheng Zhou, Yaohui Yang, Zhiyao Zhao, et al.
Annals of Medicine and Surgery (2012)|February 12, 2026
An update on tibial tubercle avulsion fractures: a narrative reviewZhiyao Zhao, Hairui Zhang, Fangzheng Zhou, et al.
Scientific Reports|July 2, 2025
Nomogram for the prediction of the prognosis of patients with triple-negative invasive ductal carcinoma of breast after neoadjuvant chemotherapyQiuyu Yang, Liangchen Xi, Mudan Huang, et al.
Oncology Reports|June 1, 2022
[Retracted] MicroRNA‑379 acts as a tumor suppressor in non‑small cell lung cancer by targeting the IGF‑1R‑mediated AKT and ERK pathwaysFangzheng Zhou, Long Nie, Dali Feng, et al.
Oncology Reports|July 22, 2017
MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF‑1R-mediated AKT and ERK pathwaysFangzheng Zhou, Long Nie, Dali Feng, et al.
Pageof 4